These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15513012)

  • 1. Diabetic macular edema: classification, medical and laser therapy.
    Bandello F; Pognuz R; Polito A; Pirracchio A; Menchini F; Ambesi M
    Semin Ophthalmol; 2003 Dec; 18(4):251-8. PubMed ID: 15513012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment approaches in diabetic macular edema.
    Meyer CH
    Ophthalmologica; 2007; 221(2):118-31. PubMed ID: 17380066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema.
    Tunc M; Onder HI; Kaya M
    Ophthalmology; 2005 Jun; 112(6):1086-91. PubMed ID: 15885789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthreshold diode laser micropulse photocoagulation for the treatment of diabetic macular edema.
    Sivaprasad S; Dorin G
    Expert Rev Med Devices; 2012 Mar; 9(2):189-97. PubMed ID: 22404779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
    Sutter FK; Simpson JM; Gillies MC
    Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
    Browning DJ; Fraser CM; Powers ME
    Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Kang SW; Park SC; Cho HY; Kang JH
    Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on treatments of diabetic macular edema.
    Yang XL; Liu K; Xu X
    Chin Med J (Engl); 2009 Nov; 122(22):2784-90. PubMed ID: 19951615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Er H
    Am J Ophthalmol; 2008 Aug; 146(2):332-3; author reply 333. PubMed ID: 18656589
    [No Abstract]   [Full Text] [Related]  

  • 13. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser.
    Parodi MB; Spasse S; Iacono P; Di Stefano G; Canziani T; Ravalico G
    Ophthalmology; 2006 Dec; 113(12):2237-42. PubMed ID: 16996596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.
    Silva PS; Sun JK; Aiello LP
    Semin Ophthalmol; 2009; 24(2):93-9. PubMed ID: 19373693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing paradigms in the treatment of diabetic retinopathy.
    El-Asrar AM; Al-Mezaine HS; Ola MS
    Curr Opin Ophthalmol; 2009 Nov; 20(6):532-8. PubMed ID: 19644368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D; Lanzetta P; Perissin L; Bandello F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology and treatment of macular edema.
    Johnson MW
    Am J Ophthalmol; 2009 Jan; 147(1):11-21.e1. PubMed ID: 18789796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
    Gillies MC; Simpson JM; Gaston C; Hunt G; Ali H; Zhu M; Sutter F
    Ophthalmology; 2009 Nov; 116(11):2182-7. PubMed ID: 19796823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.